3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Glioblastoma
527
Brain Neoplasms
415
Glioma
343
Astrocytoma
239
Central Nervous System Neoplasms
201
Neuroblastoma
195
Gliosarcoma
163
Oligodendroglioma
149
Medulloblastoma
118
Neoplasms
113
Ependymoma
72
Recurrence
70
Breast Neoplasms
69
Sarcoma
65
Melanoma
62
Carcinoma, Non-Small-Cell Lung
58
Osteosarcoma
57
Diffuse Intrinsic Pontine Glioma
48
Wilms Tumor
47
Familial ependymoma
47
Lymphoma
46
Neoplasm Metastasis
45
Optic Nerve Glioma
44
Rhabdomyosarcoma
42
Rhabdoid Tumor
42
Lung Neoplasms
42
Choroid Plexus Neoplasms
42
Neuroectodermal Tumors, Primitive
38
Meningeal Carcinomatosis
38
Ovarian Neoplasms
37
Interventions
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Skull Base Neoplasms
×
CNS
×
Clear all
NCT00870779
2019-06-14
FGR
Dartmouth-Hitchcock Medical Center
Phase 1
Completed
105 enrolled